Human endothelial cells are target for platelet-activating factor: II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells

R. Heller, F. Bussolino, D. Ghigo, G. Garbarino, G. Pescarmona, U. Till, A. Bosia

Research output: Contribution to journalArticle

Abstract

Platelet-activating factor (PAF), a phospholipid mediator with broad and potent biologic activities, is synthesized by several inflammatory cells including endothelial cells (EC). PAF is also an effective stimulating agent for EC leading to increased cell permeability and adhesivity. We examined the synthesis of PAF in human umbilical cord vein EC after stimulation of EC with PAF or with its nonmetabolizable analog 1-O-alkyl-2-N-methyl-carbamyl-sn- glycero-3-phosphocholine (C-PAF). PAF (1 to 100 nM) induced a dose- and time- dependent increase of PAF synthesis as detected by [3H]acetate incorporation into PAF fraction. Stimulation of PAF synthesis occurred via activation of the 'remodeling pathway' as the 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF):acetyl-CoA acetyltransferase was dose-dependently increased after PAF treatment. The de novo pathway of PAF synthesis was not activated under these conditions. C-PAF was able to mimic the effect of authentic PAF on [3H]acetate incorporation. The inactive metabolite lyso-PAF (100 nM) had no influence on PAF synthesis in EC. CV-3988, BN 52021, and WEB 2086, potent and specific antagonists of PAF suppressed PAF effects on the remodeling pathway completely. The PAF- and C-PAF-induced [3H]PAF remained 93% cell-associated and was not degraded up to 10 min after stimulation. Characterization of the [3H]acetate-labeled material co-migrating with authentic PAF revealed that a significant proportion (≃57%) was actually 1-acyl-2-acetyl-sn-glycero-3- phosphocholine. PAF-induced PAF synthesis might be an important mechanism for amplifying original PAF signals and potentiating adhesive interactions of circulating cells with the endothelium.

Original languageEnglish
Pages (from-to)3682-3688
Number of pages7
JournalJournal of Immunology
Volume149
Issue number11
Publication statusPublished - 1992

Fingerprint

Platelet Activating Factor
Human Umbilical Vein Endothelial Cells
Prothrombin
Endothelial Cells
ginkgolide B
Acetates
Phosphorylcholine
WEB 2086
1-alkylglycerophosphocholine acetyltransferase

ASJC Scopus subject areas

  • Immunology

Cite this

Human endothelial cells are target for platelet-activating factor : II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. / Heller, R.; Bussolino, F.; Ghigo, D.; Garbarino, G.; Pescarmona, G.; Till, U.; Bosia, A.

In: Journal of Immunology, Vol. 149, No. 11, 1992, p. 3682-3688.

Research output: Contribution to journalArticle

@article{2f054d3bfc2a4b6fa0bc6f8569f55444,
title = "Human endothelial cells are target for platelet-activating factor: II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells",
abstract = "Platelet-activating factor (PAF), a phospholipid mediator with broad and potent biologic activities, is synthesized by several inflammatory cells including endothelial cells (EC). PAF is also an effective stimulating agent for EC leading to increased cell permeability and adhesivity. We examined the synthesis of PAF in human umbilical cord vein EC after stimulation of EC with PAF or with its nonmetabolizable analog 1-O-alkyl-2-N-methyl-carbamyl-sn- glycero-3-phosphocholine (C-PAF). PAF (1 to 100 nM) induced a dose- and time- dependent increase of PAF synthesis as detected by [3H]acetate incorporation into PAF fraction. Stimulation of PAF synthesis occurred via activation of the 'remodeling pathway' as the 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF):acetyl-CoA acetyltransferase was dose-dependently increased after PAF treatment. The de novo pathway of PAF synthesis was not activated under these conditions. C-PAF was able to mimic the effect of authentic PAF on [3H]acetate incorporation. The inactive metabolite lyso-PAF (100 nM) had no influence on PAF synthesis in EC. CV-3988, BN 52021, and WEB 2086, potent and specific antagonists of PAF suppressed PAF effects on the remodeling pathway completely. The PAF- and C-PAF-induced [3H]PAF remained 93{\%} cell-associated and was not degraded up to 10 min after stimulation. Characterization of the [3H]acetate-labeled material co-migrating with authentic PAF revealed that a significant proportion (≃57{\%}) was actually 1-acyl-2-acetyl-sn-glycero-3- phosphocholine. PAF-induced PAF synthesis might be an important mechanism for amplifying original PAF signals and potentiating adhesive interactions of circulating cells with the endothelium.",
author = "R. Heller and F. Bussolino and D. Ghigo and G. Garbarino and G. Pescarmona and U. Till and A. Bosia",
year = "1992",
language = "English",
volume = "149",
pages = "3682--3688",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Human endothelial cells are target for platelet-activating factor

T2 - II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells

AU - Heller, R.

AU - Bussolino, F.

AU - Ghigo, D.

AU - Garbarino, G.

AU - Pescarmona, G.

AU - Till, U.

AU - Bosia, A.

PY - 1992

Y1 - 1992

N2 - Platelet-activating factor (PAF), a phospholipid mediator with broad and potent biologic activities, is synthesized by several inflammatory cells including endothelial cells (EC). PAF is also an effective stimulating agent for EC leading to increased cell permeability and adhesivity. We examined the synthesis of PAF in human umbilical cord vein EC after stimulation of EC with PAF or with its nonmetabolizable analog 1-O-alkyl-2-N-methyl-carbamyl-sn- glycero-3-phosphocholine (C-PAF). PAF (1 to 100 nM) induced a dose- and time- dependent increase of PAF synthesis as detected by [3H]acetate incorporation into PAF fraction. Stimulation of PAF synthesis occurred via activation of the 'remodeling pathway' as the 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF):acetyl-CoA acetyltransferase was dose-dependently increased after PAF treatment. The de novo pathway of PAF synthesis was not activated under these conditions. C-PAF was able to mimic the effect of authentic PAF on [3H]acetate incorporation. The inactive metabolite lyso-PAF (100 nM) had no influence on PAF synthesis in EC. CV-3988, BN 52021, and WEB 2086, potent and specific antagonists of PAF suppressed PAF effects on the remodeling pathway completely. The PAF- and C-PAF-induced [3H]PAF remained 93% cell-associated and was not degraded up to 10 min after stimulation. Characterization of the [3H]acetate-labeled material co-migrating with authentic PAF revealed that a significant proportion (≃57%) was actually 1-acyl-2-acetyl-sn-glycero-3- phosphocholine. PAF-induced PAF synthesis might be an important mechanism for amplifying original PAF signals and potentiating adhesive interactions of circulating cells with the endothelium.

AB - Platelet-activating factor (PAF), a phospholipid mediator with broad and potent biologic activities, is synthesized by several inflammatory cells including endothelial cells (EC). PAF is also an effective stimulating agent for EC leading to increased cell permeability and adhesivity. We examined the synthesis of PAF in human umbilical cord vein EC after stimulation of EC with PAF or with its nonmetabolizable analog 1-O-alkyl-2-N-methyl-carbamyl-sn- glycero-3-phosphocholine (C-PAF). PAF (1 to 100 nM) induced a dose- and time- dependent increase of PAF synthesis as detected by [3H]acetate incorporation into PAF fraction. Stimulation of PAF synthesis occurred via activation of the 'remodeling pathway' as the 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF):acetyl-CoA acetyltransferase was dose-dependently increased after PAF treatment. The de novo pathway of PAF synthesis was not activated under these conditions. C-PAF was able to mimic the effect of authentic PAF on [3H]acetate incorporation. The inactive metabolite lyso-PAF (100 nM) had no influence on PAF synthesis in EC. CV-3988, BN 52021, and WEB 2086, potent and specific antagonists of PAF suppressed PAF effects on the remodeling pathway completely. The PAF- and C-PAF-induced [3H]PAF remained 93% cell-associated and was not degraded up to 10 min after stimulation. Characterization of the [3H]acetate-labeled material co-migrating with authentic PAF revealed that a significant proportion (≃57%) was actually 1-acyl-2-acetyl-sn-glycero-3- phosphocholine. PAF-induced PAF synthesis might be an important mechanism for amplifying original PAF signals and potentiating adhesive interactions of circulating cells with the endothelium.

UR - http://www.scopus.com/inward/record.url?scp=0026468459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026468459&partnerID=8YFLogxK

M3 - Article

C2 - 1431139

AN - SCOPUS:0026468459

VL - 149

SP - 3682

EP - 3688

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -